Compositions and methods for inhibiting expression of CD274/PD-L1 gene

Details for Australian Patent Application No. 2011237630 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Defougerolles, Antonin; Novobrantseva, Tatiana; Bettencourt, Brian

Agent Pizzeys

Pub. Number AU-A-2011237630

PCT Pub. Number WO2011/127180

Priority 61/321,263 06.04.10 US

Filing date 6 April 2011

Wipo publication date 13 October 2011

International Classifications

A61K 31/713 - Double-stranded nucleic acids or oligonucleotides

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/127180 Priority application(s): WO2011/127180

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237638-Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

2011237629-Glycomimetic compounds and methods to inhibit infection by HIV